Upregulation of cerebrospinal fluid and peripheral prostaglandin E2 in a rat postoperative pain model

被引:40
|
作者
Kroin, Jeffrey S. [1 ]
Buvanendran, Asokumar [1 ]
Watts, Daniel E. [1 ]
Saha, Chiranjeev [1 ]
Tuman, Kenneth J. [1 ]
机构
[1] Rush Med Coll, Dept Anesthesiol, Chicago, IL 60612 USA
来源
ANESTHESIA AND ANALGESIA | 2006年 / 103卷 / 02期
关键词
D O I
10.1213/01.ane.0000223674.52364.5c
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Analgesic management of postoperative pain associated with thoracic surgery remains a difficult clinical challenge. In the present study we used a thoracic muscle incision model to characterize pain-related behavior and changes in prostaglandin E-2 (PGE(2)) in both thoracic cerebrospinal fluid (CSF) and incision site tissues. A deep muscle incision was made in the left thoracic region of rats anesthetized with isoflurane, propofol, or spinal bupivacaine. Thoracic CSF and incision site tissue concentrations of PGE(2) were monitored for 6 h using microdialysis loop catheters. Postoperative pain-related behavior was assessed by recording exploratory locomotive activity. Thoracic muscle surgery decreased rearing and ambulation. Oral ketorolac or rofecoxib 3 mg/kg restored normal rearing and ambulation. Postoperative CSF PGE(2) concentration increased most (threefold) with spinal anesthesia, and not at all with propofol. With surgery under isoflurane or spinal bupivacaine, presurgical oral administration of ketorolac or rofecoxib 3 mg/kg reduced postsurgical CSF PGE(2) levels and tissue PGE(2) levels. Intrathecal ketorolac (4 mu g) reduced CSF PGE2 after surgery without affecting tissue PGE(2) levels, whereas intrathecal L-745,337 (80 mu g) did not reduce CSF PGE(2) Thoracic surgical wounds increase pain-related behavior and CSF and tissue PGE(2) levels, all of which can be attenuated by oral cyclooxygenase inhibitors.
引用
收藏
页码:334 / 343
页数:10
相关论文
共 50 条
  • [31] A Murine Empyema Model: A Role For Prostaglandin E2
    Tucker, T. A.
    Jeffers, A.
    Owens, S.
    Boren, J.
    Koenig, K.
    Quaid, B.
    Idell, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [32] The activity of prostaglandin E2 (PGE2) in cerebrospinal fluid (CSF) from amyotrophic lateral sclerosis (ALS) patients
    Ostrowska, M.
    Partyka, D.
    Bielanski, W.
    Tomik, B.
    Szczudlik, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 95 - 96
  • [33] Prostaglandin E2 induces apoptosis in cultured rat microglia
    Nagano, Takayuki
    Kimura, Shinya H.
    Takemura, Motohiko
    BRAIN RESEARCH, 2014, 1568 : 1 - 9
  • [34] Prostaglandin E2 activates the histaminergic system in the rat brain
    Huang, ZL
    Mochizuki, T
    Okada, T
    Hayaishi, O
    Urade, Y
    OXYGEN AND LIFE: OXYGENASES, OXIDASE AND LIPID MEDIATORS, 2002, 1233 : 441 - 445
  • [35] Prostaglandin E2 stimulate glucose absorption in rat intestine?
    Somasundaram, S
    GUT, 2000, 46 (01) : 141 - 142
  • [36] HYPERHOMOCYSTEINEMIA INCREASES CYTOKINES AND PROSTAGLANDIN E2 IN RAT HIPPOCAMPUS
    Cunha, A. A.
    Ferreira, A. G. K.
    da Cunha, M. J.
    Schmitz, F.
    Netto, C. A.
    Wyse, A. T. S.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2011, 34 : S113 - S113
  • [37] Role of the blood-cerebrospinal fluid barrier transporter as a cerebral clearance system for prostaglandin E2 produced in the brain
    Tachikawa, Masanori
    Ozeki, Go
    Higuchi, Takanori
    Akanuma, Shin-ichi
    Tsuji, Kazuhiro
    Hosoya, Ken-ichi
    JOURNAL OF NEUROCHEMISTRY, 2012, 123 (05) : 750 - 760
  • [38] Prostaglandin E2 induces apoptosis in cultured rat microglia
    Nagano, Takayuki
    KImura, Shinya H.
    Takemura, Motohiko
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2013, 121 : 215P - 215P
  • [39] Impairment of blood-cerebrospinal fluid barrier properties by retrovirus-activated T lymphocytes:: reduction in cerebrospinal fluid-to-blood efflux of prostaglandin E2
    Khuth, ST
    Strazielle, N
    Giraudon, P
    Belin, MF
    Ghersi-Egea, JF
    JOURNAL OF NEUROCHEMISTRY, 2005, 94 (06) : 1580 - 1593
  • [40] Prostaglandin E2, an Immunoactivator
    Sakata, Daiji
    Yao, Chengcan
    Narumiya, Shuh
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 112 (01) : 1 - 5